Friday, January 5, 2018

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Intends to Capitalize on Growing Lithium Need in China

As Chinese buyers seem to be increasingly interested in Canadian lithium producers, Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is stepping up its exploration efforts in the US. The Canadian energy exploration and development company hopes to profit from the booming demand for lithium resulting from the giant auto industry in China. An article discussing this reads: “China, which has the world’s largest auto market, is undoubtedly in pole position in the EV race. The Chinese government, seeking to cap carbon emissions, plans to phase out vehicles using gasoline and diesel by 2030, after which time only EVs will be sold. Climbing production of EVs is driving up demand for lithium. Battery-grade lithium has been trading at $20,000 a ton on the Chinese spot market, according to Fortune (http://dtn.fm/4KpOa). With prices that lofty, Standard Lithium is stepping up its efforts to get the metal out of the ground. Its first project in San Bernardino County, California, at the Bristol Dry Lake has already started to show signs of promise. This past May, Standard Lithium signed an option agreement to conduct lithium exploration and project development under long-standing mineral claims and permits on the Bristol Dry Lake playa held by National Chloride Corporation of America. Test results from a new geophysical survey of the 35,000-acre Bristol Lake site indicate that high concentrations of lithium-bearing brines are present throughout the company’s mineral lease agreement claims.”
To view the full article, visit http://dtn.fm/BAet2
About Standard Lithium Ltd.
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Thursday, January 4, 2018

MissionIRNewsBreaks – DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) Northern Lights Subsidiary Making Strides Toward Sales License

Premium cannabis lifestyle brand DOJA Cannabis Company’s (CSE: DOJA) (OTC: DJACF) wholly owned subsidiary, Northern Lights Marijuana Company, is a Health Canada licensed cannabis producer on the track to gain a Sales License. An article discussing the company reads: “DOJA’s initial cannabis harvest, produced under the Access to Cannabis for Medical Purposes Regulations (ACMPR) license held by its subsidiary, Northern Lights Marijuana Company, will be inspected by Health Canada regulators as the last step before a Sales License can be awarded. Once DOJA passes this major milestone and receives its Sales License, the company can begin selling cannabis and position itself as a premium handcrafted producer in advance of the impending recreational market.”
To view the full article, visit http://dtn.fm/S8xSN
About DOJA Cannabis Company Limited
DOJA™ is a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. DOJA’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. DOJA’s state-of-the-art ACMPR licensed production facility is located in the heart of British Columbia’s picturesque Okanagan Valley. DOJA was founded by the proven entrepreneurial team that started SAXX Underwear®. For more information, visit the company’s website at www.DOJA.life.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Tuesday, January 2, 2018

DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) is “One to Watch”

  • Premium cannabis lifestyle brand founded by team that started SAXX Underwear®
  • One of only 26 Health Canada licensed cannabis production facilities
  • Canada’s recreational marijuana market estimated at up to $8.7 billion
  • Initial cannabis harvests are complete; awaiting Health Canada pre-sales inspection
DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) is a premium cannabis lifestyle brand featuring the highest quality handcrafted strains in Canada. DOJA’s wholly owned subsidiary, Northern Lights Marijuana Company, is a Health Canada licensed cannabis producer located in Kelowna within the heart of British Columbia’s picturesque Okanagan Valley.
Famous as the “Napa of the North,” Kelowna and its rapidly growing tourism industry accounted for 1.9 million visitors in 2106. DOJA co-founder and CEO Trent Kitsch said the company’s phase 1 facility – a 7,100 square foot building in West Kelowna – houses three grow rooms, each capable of producing 660 kilograms of marijuana per year. The grow rooms are outfitted with state-of-the-art equipment engineered specifically for indoor cannabis cultivation.
DOJA’s initial cannabis harvest, produced under the Access to Cannabis for Medical Purposes Regulations (ACMPR) license held by its subsidiary, Northern Lights Marijuana Company, will be inspected by Health Canada regulators as the last step before a Sales License can be awarded. Once DOJA passes this major milestone and receives its Sales License, the company can begin selling cannabis and position itself as a premium handcrafted producer in advance of the impending recreational market.
“I’m extremely proud of our cultivation team, they have delivered on all levels, the quality of our flower is impressive, and the yields exceeded our expectations. Our growers focus on bringing out the fullest expression of the plant’s genetic potential and the love and hard work they have put into their craft really shows in our first four strains,” Kitsch said. “Post-harvest, our flowers were expertly hand-trimmed, hang-dried and artisanally cured. Our handcrafted approach is aimed at producing the finest cannabis with exceptional aroma, flavor and effects.”
Each grow room is established with Surna’s equipment, providing ductless air handlers, commercial-grade dehumidifiers, and biosecurity products using photocatalytic reaction to sanitize the air and minimize breakouts of pests, pathogens and mold. DOJA’s expansion plans include the ability to add over 40,000 square feet, which would increase the company’s overall production capacity to more than 5,000 kilograms per year. Once completed and producing, the company’s potential revenue, excluding cannabis oil products, is estimated at $60 million.
According to a recent report, DOJA is well capitalized with approximately $4.5 million cash with management holding 33 percent of the shares outstanding. DOJA was founded by the proven entrepreneurial team that started the industry disruptive men’s SAXX Underwear® brand. Kitsch is joined by Ria Kitsch as vice-president and co-founder; Ryan Foreman, president and co-founder; and Jeff Barber, CFO, as DOJA’s “cannabis futurists.”
For more information, visit the company’s website at www.DOJA.life
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Venture Builder Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) Boosts Emerging Tech Interests

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) is helping promising entrepreneurs in a variety of emerging fields including blockchain technology, virtual reality, artificial intelligence, and personalized health to find an international reach through funding and partnership building. Its portfolio includes social sports betting that uses blockchain tech, personalized health tech such as predictive diabetes test kits, motion picture production with Academy Award winner networking, and legal cannabis options with a green impact footprint. An article discussing this reads: “Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, (CEO Shafin Diamond) Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents.”
To view the full article, visit http://dtn.fm/Ar1Y8
About Victory Square Technologies Inc.
Victory Square is a venture builder that creates, funds and empowers entrepreneurs predominantly focused on Blockchain Technology, Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources and other forms of operational support to help them scale internationally. For more information, visit the company’s website at www.VictorySquare.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Cannabis-based Eating Disorder Treatment Anticipated for PCT Filing in February

India Globalization Capital (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, has recently developed IGC-506 for the treatment of multiple types of eating disorders in humans, as well as animals in the veterinary market. The company expects to file a Patent Cooperation Treaty (“PCT”) application by February 28, 2018. PCT is an international patent filing effective in numerous foreign countries. An article discussing this reads: “IGC-506 is a combination therapy drug, developed from cannabis-extracts and other compounds, designed to treat multiple types of eating disorders. Cannabinoids are chemical compounds that exert a range of effects on the body. The non-psychoactive phytocannabinoid, cannabidiol (CBD), influences many pathways in humans, as well as cats and dogs, and may be used to provide relief for numerous symptoms ranging from pain to eating disorders.”
To view the full article, visit http://dtn.fm/topY0
About IGC
IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.IGCInc.us.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html